PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PATH vs. OPRA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


PATHOPRA
YTD Return-49.24%50.17%
1Y Return-18.80%71.57%
3Y Return (Ann)-37.00%40.00%
Sharpe Ratio-0.281.16
Sortino Ratio0.012.04
Omega Ratio1.001.23
Calmar Ratio-0.191.04
Martin Ratio-0.444.63
Ulcer Index37.58%13.90%
Daily Std Dev58.88%55.40%
Max Drawdown-87.61%-72.85%
Current Drawdown-85.19%-28.61%

Fundamentals


PATHOPRA
Market Cap$6.93B$1.66B
EPS-$0.20$1.80
Total Revenue (TTM)$1.38B$325.34M
Gross Profit (TTM)$1.16B$175.14M
EBITDA (TTM)-$156.65M$70.32M

Correlation

-0.50.00.51.00.4

The correlation between PATH and OPRA is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

PATH vs. OPRA - Performance Comparison

In the year-to-date period, PATH achieves a -49.24% return, which is significantly lower than OPRA's 50.17% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctober
-34.64%
46.18%
PATH
OPRA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PATH vs. OPRA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for UiPath Inc. (PATH) and Opera Limited (OPRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PATH
Sharpe ratio
The chart of Sharpe ratio for PATH, currently valued at -0.28, compared to the broader market-4.00-2.000.002.004.00-0.28
Sortino ratio
The chart of Sortino ratio for PATH, currently valued at 0.01, compared to the broader market-4.00-2.000.002.004.006.000.01
Omega ratio
The chart of Omega ratio for PATH, currently valued at 1.00, compared to the broader market0.501.001.502.001.00
Calmar ratio
The chart of Calmar ratio for PATH, currently valued at -0.19, compared to the broader market0.002.004.006.00-0.19
Martin ratio
The chart of Martin ratio for PATH, currently valued at -0.44, compared to the broader market-10.000.0010.0020.0030.00-0.44
OPRA
Sharpe ratio
The chart of Sharpe ratio for OPRA, currently valued at 1.16, compared to the broader market-4.00-2.000.002.004.001.16
Sortino ratio
The chart of Sortino ratio for OPRA, currently valued at 2.04, compared to the broader market-4.00-2.000.002.004.006.002.04
Omega ratio
The chart of Omega ratio for OPRA, currently valued at 1.23, compared to the broader market0.501.001.502.001.23
Calmar ratio
The chart of Calmar ratio for OPRA, currently valued at 1.04, compared to the broader market0.002.004.006.001.04
Martin ratio
The chart of Martin ratio for OPRA, currently valued at 4.63, compared to the broader market-10.000.0010.0020.0030.004.63

PATH vs. OPRA - Sharpe Ratio Comparison

The current PATH Sharpe Ratio is -0.28, which is lower than the OPRA Sharpe Ratio of 1.16. The chart below compares the historical Sharpe Ratios of PATH and OPRA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00JuneJulyAugustSeptemberOctober
-0.28
1.16
PATH
OPRA

Dividends

PATH vs. OPRA - Dividend Comparison

PATH has not paid dividends to shareholders, while OPRA's dividend yield for the trailing twelve months is around 4.28%.


TTM2023
PATH
UiPath Inc.
0.00%0.00%
OPRA
Opera Limited
4.28%9.07%

Drawdowns

PATH vs. OPRA - Drawdown Comparison

The maximum PATH drawdown since its inception was -87.61%, which is greater than OPRA's maximum drawdown of -72.85%. Use the drawdown chart below to compare losses from any high point for PATH and OPRA. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JuneJulyAugustSeptemberOctober
-85.19%
-28.61%
PATH
OPRA

Volatility

PATH vs. OPRA - Volatility Comparison

The current volatility for UiPath Inc. (PATH) is 10.06%, while Opera Limited (OPRA) has a volatility of 13.33%. This indicates that PATH experiences smaller price fluctuations and is considered to be less risky than OPRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctober
10.06%
13.33%
PATH
OPRA

Financials

PATH vs. OPRA - Financials Comparison

This section allows you to compare key financial metrics between UiPath Inc. and Opera Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items